REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,928,211 | +9.7% | 342,477 | +142.0% | 1.22% | +33.5% |
| Q2 2023 | $3,581,365 | +151.7% | 141,500 | +61.3% | 0.91% | +168.7% |
| Q4 2019 | $1,423,000 | -64.2% | 87,700 | -71.3% | 0.34% | -73.5% |
| Q3 2019 | $3,974,000 | -24.1% | 305,664 | -24.3% | 1.28% | +1.4% |
| Q2 2019 | $5,236,000 | +30.5% | 403,664 | +58.6% | 1.26% | +16.5% |
| Q1 2019 | $4,012,000 | +18.8% | 254,581 | +51.8% | 1.08% | -12.0% |
| Q4 2018 | $3,376,000 | -17.3% | 167,724 | +2.1% | 1.23% | -12.2% |
| Q3 2018 | $4,084,000 | +46.9% | 164,353 | +62.3% | 1.40% | -8.8% |
| Q2 2018 | $2,780,000 | – | 101,292 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |